Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oncology Institute (TOI) EPS (Basic) (2020 - 2025)

Oncology Institute's EPS (Basic) history spans 6 years, with the latest figure at -$0.05 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 66.67% year-over-year to -$0.05; the TTM value through Dec 2025 reached -$0.55, up 23.61%, while the annual FY2025 figure was -$0.54, 23.94% up from the prior year.
  • EPS (Basic) reached -$0.05 in Q4 2025 per TOI's latest filing, up from -$0.14 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.22 in Q1 2022 to a low of -$0.33 in Q1 2023.
  • Average EPS (Basic) over 5 years is -$0.12, with a median of -$0.15 recorded in 2021.
  • Peak YoY movement for EPS (Basic): plummeted 850.0% in 2021, then skyrocketed 1200.0% in 2022.
  • A 5-year view of EPS (Basic) shows it stood at -$0.15 in 2021, then increased by 20.0% to -$0.12 in 2022, then crashed by 75.0% to -$0.21 in 2023, then increased by 28.57% to -$0.15 in 2024, then skyrocketed by 66.67% to -$0.05 in 2025.
  • Per Business Quant, the three most recent readings for TOI's EPS (Basic) are -$0.05 (Q4 2025), -$0.14 (Q3 2025), and -$0.15 (Q2 2025).